Cite
HARVARD Citation
Jensen, D. et al. (n.d.). 821Daclatasvir and Asunaprevir Plus Peginterferon Alfa-2a and Ribavirin in Patients With HCV Genotype 1 or 4 Infection: Phase 3 HALLMARK-QUAD Results. Open forum infectious diseases. p. S234. [Online].